Michael Becker to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Michael Becker has written about Xenograft Model Antitumor Assays.
Connection Strength
0.166
-
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun. 2017 02 10; 8:14262.
Score: 0.112
-
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP. Clin Cancer Res. 2018 05 15; 24(10):2452-2463.
Score: 0.030
-
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia. Mol Cancer Ther. 2014 Aug; 13(8):1979-90.
Score: 0.023